CompaniesRanked

2874 companies · fiscal year 2025 · SEC EDGAR · September 25, 2026

Largest healthcare companies by revenue — page 2

Ranks 101–200 of 322 · Fiscal year 2025 · Data as of September 25, 2026

Revenue
#CompanyRevenueYoY15-year trend
101Kindercare Learning CompaniesKLCUS$2.7B+2.6%
102QuidelorthoQDELUS$2.7B−1.9%
103Fortrea HoldingsFTREUS$2.7B+1.0%
104Envista HoldingsNVSTUS$2.7B+8.3%
105InsuletPODDUS$2.7B+30.7%
106Medpace HoldingsMEDPUS$2.5B+20.0%
107ChemedCHEUS$2.5B+4.1%
108Teladoc HealthTDOCUS$2.5B−1.5%
109Aveanna HealthcareAVAHUS$2.4B+20.2%
110Royalty PharmaRPRXUS$2.4B+5.1%
111Hims & Hers HealthHIMSUS$2.3B+59.0%
112ExelixisEXELUS$2.3B+7.0%
113NateraNTRAUS$2.3B+35.9%
114EnovisENOVUS$2.2B+6.7%
115Icu MedicalICUIUS$2.2B−6.3%
116Sarepta TherapeuticsSRPTUS$2.2B+15.6%
117Concentra Group Holdings ParentCONUS$2.2B+13.9%
118Privia HealthPRVAUS$2.1B+22.3%
119QiagenQGENNL$2.1B+5.7%
120RadnetRDNTUS$2.0B+11.5%
121TeleflexTFXUS$2.0B+17.2%
122National VisionEYEUS$2.0B+9.0%
123ModernaMRNAUS$1.9B−39.9%
124Clover Health InvestmentsCLOVUS$1.9B+40.3%
125Pediatrix MedicalMDUS$1.9B−4.9%
126Msa SafetyMSAUS$1.9B+3.7%
127Integer HoldingsITGRUS$1.9B+8.0%
128Healthcare ServicesHCSGUS$1.8B+7.1%
129111YICN$1.8B−9.0%
130PTC TherapeuticsPTCTUS$1.7B+114.5%
131Integra LifesciencesIARTUS$1.6B+1.5%
132Lantheus HoldingsLNTHUS$1.5B+0.5%
133National HealthcareNHCUS$1.5B+16.1%
134Merit Medical SystemsMMSIUS$1.5B+11.8%
135Nu Skin EnterprisesNUSUS$1.5B−14.3%
136AlkermesALKSIE$1.5B−5.2%
137P3 Health PartnersPIIIUS$1.5B−2.8%
138Guardian Pharmacy ServicesGRDNUS$1.4B+17.9%
139TrupanionTRUPUS$1.4B+11.9%
140Lifestance HealthLFSTUS$1.4B+13.9%
141Addus HomecareADUSUS$1.4B+23.2%
142PenumbraPENUS$1.4B+17.5%
143Halozyme TherapeuticsHALOUS$1.4B+37.6%
144LivanovaLIVNGB$1.4B+10.7%
145ConmedCNMDUS$1.4B+5.2%
146Stevanato GroupSTVNIT$1.3B+12.2%
147HaemoneticsHAEUS$1.3B−2.0%
148Phibro Animal HealthPAHCUS$1.3B+27.4%
149ProgynyPGNYUS$1.3B+10.4%
150Curaleaf HoldingsCURLFUS$1.3B−5.0%
151Lakefront BiotherapeuticsLKFTBE$1.3B+321.2%
152Indivior PharmaceuticalsINDVUS$1.2B+4.3%
153Bio-TechneTECHUS$1.2B+5.2%
154Trulieve CannabisTRLVUS$1.2B−0.4%
155Sotera HealthSHCUS$1.2B+5.7%
156NovavaxNVAXUS$1.1B+64.7%
157Prestige Consumer HealthcarePBHUS$1.1B−4.3%
158EmbectaEMBCUS$1.1B−3.8%
159Acadia PharmaceuticalsACADUS$1.1B+11.9%
160Legend BiotechLEGNUS$1.0B+64.0%
161Tandem Diabetes CareTNDMUS$1.0B+7.9%
162Guardant HealthGHUS$982M+32.9%
163Madrigal PharmaceuticalsMDGLUS$958M+432.1%
164Pennant GroupPNTGUS$948M+36.3%
165Ionis PharmaceuticalsIONSUS$944M+33.8%
166Usana Health SciencesUSNAUS$925M+8.3%
167Tilray BrandsTLRYUS$915M+11.5%
168Inspire Medical SystemsINSPUS$912M+13.6%
169Ani PharmaceuticalsANIPUS$883M+43.8%
170Biocryst PharmaceuticalsBCRXUS$875M+94.1%
171Warby ParkerWRBYUS$872M+13.0%
172NeogenNEOGUS$870M−2.7%
173Harmony BiosciencesHRMYUS$868M+21.5%
174Innovage HoldingINNVUS$854M+11.8%
175Arrowhead PharmaceuticalsARWRUS$829M+23,258.2%
176Myriad GeneticsMYGNUS$825M−1.6%
177Orthofix MedicalOFIXUS$822M+2.9%
178Ascendis PharmaASNDDK$814M+106.7%
179Caris Life SciencesCAIUS$812M+97.0%
180Telix PharmaceuticalsTLXAU$804M+55.6%
181U S Physical TherapyUSPHUS$781M+16.3%
182Collegium PharmaceuticalCOLLUS$781M+23.6%
183Alphatec HoldingsATECUS$764M+25.0%
184Corcept TherapeuticsCORTUS$761M+12.8%
185Irhythm HoldingsIRTCUS$747M+26.2%
186Emergent BiosolutionsEBSUS$743M−28.8%
187RepligenRGENUS$738M+16.4%
188Pacira BiosciencesPCRXUS$726M+3.6%
189Amphastar PharmaceuticalsAMPHUS$720M−1.7%
190Supernus PharmaceuticalsSUPNUS$719M+8.6%
191Avanos MedicalAVNSUS$701M+1.9%
192Kiniksa Pharmaceuticals InternationalKNSAGB$678M+60.1%
193SNDLSNDLCA$677M+0.8%
194Ultragenyx PharmaceuticalRAREUS$673M+20.2%
195Cresco LabsCRLBFUS$656M−9.5%
196NovocureNVCR$655M+8.3%
197Axsome TherapeuticsAXSMUS$638M+65.5%
198TG TherapeuticsTGTXUS$616M+87.3%
199Cadre HoldingsCDREUS$610M+7.5%
200Opko HealthOPKUS$607M−14.9%

All figures from SEC filings · FY2025 · 100

see sources

Download this data as a CSV →

Largest companies by revenue →

By sector

By country